Skip to main content
Clinical Trials/KCT0008580
KCT0008580
Not Yet Recruiting
N/A

Effect and Safety of Integrative Treatment Program for Patients with Autism Spectrum Disorder: A Prospective Observational Study

Gachon University0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
Gachon University
Enrollment
50
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Male and female children aged 12 to 30 months
  • 2\) Those who meet the criteria for autism spectrum disorder in the DSM\-5
  • 3\) A child who has been diagnosed with autism spectrum disorder mild concern or higher on the toddler module, or autism spectrum disorder or autism on the module 2 by ADOS 2 test by a qualified clinical psychologist
  • 4\) A person whose legal representative voluntarily signed an IRB\-approved research consent form

Exclusion Criteria

  • 1\) In case of accompanying neurological abnormalities (epilepsy, cerebral palsy, Down syndrome, etc.)
  • 2\) Those diagnosed with attention deficit hyperactivity disorder, schizophrenia, etc.
  • 3\) A person diagnosed with a serious chronic or terminal disease (malignant tumor, tuberculosis, etc.)
  • 4\) If you are taking risperidone or aripiprazole, it has been less than 3 months since you stopped taking it
  • 5\) If you are taking health functional food to improve autism spectrum disorder, a person who has been taking it for less than 2 weeks after stopping taking it
  • 6\) Those who are judged unsuitable for participation in research by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials